50
Views
87
CrossRef citations to date
0
Altmetric
Review

Haemodynamic and Transport Barriers to the Treatment of Solid Tumours

, &
Pages 85-100 | Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Xiao-Yan Zhang, Li Zhang, Na Li, Qing-Li Zhu, Jian-Chu Li, Qiang Sun, Hong-Yan Wang & Yu-Xin Jiang. (2019) Vascular index measured by smart 3-D superb microvascular imaging can help to differentiate malignant and benign breast lesion. Cancer Management and Research 11, pages 5481-5487.
Read now
Xinjian Mao, Sarah McManaway, Jagdish K. Jaiswal, Cho R. Hong, William R. Wilson & Kevin O. Hicks. (2019) Schedule-dependent potentiation of chemotherapy drugs by the hypoxia-activated prodrug SN30000. Cancer Biology & Therapy 20:9, pages 1258-1269.
Read now
Margo Steuperaert, Giuseppe Falvo D’Urso Labate, Charlotte Debbaut, Olivier De Wever, Christian Vanhove, Wim Ceelen & Patrick Segers. (2017) Mathematical modeling of intraperitoneal drug delivery: simulation of drug distribution in a single tumor nodule. Drug Delivery 24:1, pages 491-501.
Read now
Young Min Kwon, Yongtao Li, Sarita Naik, Jun Feng Liang, Yongzhuo Huang, Yoon Jeong Park & Victor C Yang. (2008) The ATTEMPTS delivery systems for macromolecular drugs. Expert Opinion on Drug Delivery 5:11, pages 1255-1266.
Read now
Jeffrey M. Skolnik & Peter C. Adamson. (2007) Tyrosine Kinase Inhibitors in Pediatric Malignancies. Cancer Investigation 25:7, pages 606-612.
Read now
Nancy Smyth Templeton. (2003) Myths concerning the use of cationic liposomes in vivo. Expert Opinion on Biological Therapy 3:1, pages 57-69.
Read now
A. Mayer$suffix/text()$suffix/text(), E. Tsiompanou$suffix/text()$suffix/text(), A. A. Flynn$suffix/text()$suffix/text(), R. B. Pedley$suffix/text()$suffix/text(), J. Dearling$suffix/text()$suffix/text(), R. Boden & R. H. J. Begent$suffix/text()$suffix/text(). (2003) Higher Dose and Dose-Rate in Smaller Tumors Result in Improved Tumor Control. Cancer Investigation 21:3, pages 382-388.
Read now

Articles from other publishers (80)

Hooman Salavati, Pim Pullens, Charlotte Debbaut & Wim Ceelen. (2023) Hydraulic conductivity of human cancer tissue: A hybrid study. Bioengineering & Translational Medicine.
Crossref
M. Soltani, Mohammad Masoud Momeni, Anahita Piranfar, Mohsen Rezaeian, Saptarshi Kar & Farshad Moradi Kashkooli. 2023. Exploring Drug Delivery to the Peritoneum. Exploring Drug Delivery to the Peritoneum 169 194 .
Hooman Salavati, Charlotte Debbaut, Pim Pullens & Wim Ceelen. (2022) Interstitial fluid pressure as an emerging biomarker in solid tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:5, pages 188792.
Crossref
Bernard Gallez. (2022) The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia. Frontiers in Pharmacology 13.
Crossref
Jorgelindo da Veiga Moreira, Lenny De Staercke, Pablo César Martínez-Basilio, Sandrine Gauthier-Thibodeau, Léa Montégut, Laurent Schwartz & Mario Jolicoeur. (2021) Hyperosmolarity Triggers the Warburg Effect in Chinese Hamster Ovary Cells and Reveals a Reduced Mitochondria Horsepower. Metabolites 11:6, pages 344.
Crossref
Minoo Hamraz, Raymond Abolhassani, Mireille Andriamihaja, Céline Ransy, Véronique Lenoir, Laurent Schwartz & Frédéric Bouillaud. (2019) Hypertonic external medium represses cellular respiration and promotes Warburg/Crabtree effect. The FASEB Journal 34:1, pages 222-236.
Crossref
Tista Roy Chaudhuri & Robert M. Straubinger. 2019. Nervous System Drug Delivery. Nervous System Drug Delivery 229 250 .
Richard Kim, E Gabriela Chiorean, Manik Amin, Caio Max S Rocha-Lima, Jitendra Gandhi, William P Harris, Tao Song & David Portnoy. (2017) Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment. British Journal of Cancer 117:2, pages 189-194.
Crossref
Margo Steuperaert, Charlotte Debbaut, Patrick Segers & Wim Ceelen. (2017) Modelling drug transport during intraperitoneal chemotherapy. Pleura and Peritoneum 2:2, pages 73-83.
Crossref
Mie K. Lam, Chris Oerlemans, Martijn Froeling, Roel Deckers, Angelique D. Barten-Van Rijbroek, Max A. Viergever, Chrit T. W. Moonen, Clemens Bos & Lambertus W. Bartels. (2016) DCE-MRI and IVIM-MRI of rabbit Vx2 tumors treated with MR-HIFU-induced mild hyperthermia. Journal of Therapeutic Ultrasound 4:1.
Crossref
Joseph Gerard Jurcic, Jeffrey Y.C. Wong, Susan J. Knox, Daniel R. Wahl, Todd L. Rosenblat & Ruby F. Meredith. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology 399 418.e14 .
Huining He, Qiuling Liang, Meong Cheol Shin, Kyuri Lee, Junbo Gong, Junxiao Ye, Quan Liu, Jingkang Wang & Victor Yang. (2013) Significance and strategies in developing delivery systems for bio-macromolecular drugs. Frontiers of Chemical Science and Engineering 7:4, pages 496-507.
Crossref
Tista Roy Chaudhuri, Robert D. Arnold, Jun Yang, Steven G. Turowski, Yang Qu, Joseph A. Spernyak, Richard Mazurchuk, Donald E. Mager & Robert M. Straubinger. (2012) Mechanisms of Tumor Vascular Priming by a Nanoparticulate Doxorubicin Formulation. Pharmaceutical Research 29:12, pages 3312-3324.
Crossref
Wenxiang Zhi, Xingang Gu, Jianmin Qin, Peihao Yin, Xia Sheng, Sizhi Paul Gao & Qi Li. (2012) Solid Breast Lesions: Clinical Experience with US-guided Diffuse Optical Tomography Combined with Conventional US. Radiology 265:2, pages 371-378.
Crossref
Nancy Smyth Templeton & Neil Senzer. (2012) Reversible Masking Using Low-Molecular-Weight Neutral Lipids to Achieve Optimal-Targeted Delivery. Journal of Drug Delivery 2012, pages 1-9.
Crossref
Alexandre Cochet, Sophie Pigeonnat, Blandine Khoury, Jean-Marc Vrigneaud, Claude Touzery, Alina Berriolo-Riedinger, Inna Dygai-Cochet, Michel Toubeau, Olivier Humbert, Bruno Coudert, Pierre Fumoleau, Laurent Arnould & François Brunotte. (2012) Evaluation of Breast Tumor Blood Flow with Dynamic First-Pass 18 F-FDG PET/CT: Comparison with Angiogenesis Markers and Prognostic Factors . Journal of Nuclear Medicine 53:4, pages 512-520.
Crossref
Peng Guo & Bingmei M. Fu. (2012) Effect of Wall Compliance and Permeability on Blood-Flow Rate in Counter-Current Microvessels Formed From Anastomosis During Tumor-Induced Angiogenesis. Journal of Biomechanical Engineering 134:4.
Crossref
Ruby F. Meredith, Jeffrey Y.C. Wong & Susan J. Knox. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology e22-1 e22-46 .
M. P. J. Kuenen, M. Mischi & H. Wijkstra. (2011) Contrast-Ultrasound Diffusion Imaging for Localization of Prostate Cancer. IEEE Transactions on Medical Imaging 30:8, pages 1493-1502.
Crossref
David A. Mankoff. 2011. Principles of Anticancer Drug Development. Principles of Anticancer Drug Development 275 302 .
Shan-Shan You, Yu-Xin Jiang, Qing-Li Zhu, Ji-Bin Liu, Jing Zhang, Qing Dai, He Liu & Qiang Sun. (2009) US-guided diffused optical tomography: a promising functional imaging technique in breast lesions. European Radiology 20:2, pages 309-317.
Crossref
Benjamin L. Viglianti, Michael Lora-Michiels, Jeanie M. Poulson, Lan Lan, Dahio Yu, Linda Sanders, Oana Craciunescu, Zeljko Vujaskovic, Donald E. Thrall, James MacFall, Cecil H. Charles, Terence Wong & Mark W. Dewhirst. (2009) Dynamic Contrast-enhanced Magnetic Resonance Imaging as a Predictor of Clinical Outcome in Canine Spontaneous Soft Tissue Sarcomas Treated with Thermoradiotherapy. Clinical Cancer Research 15:15, pages 4993-5001.
Crossref
Thomas W. Miller, Jeff S. Isenberg & David D. Roberts. (2009) Molecular Regulation of Tumor Angiogenesis and Perfusion via Redox Signaling. Chemical Reviews 109:7, pages 3099-3124.
Crossref
Nancy Smyth Templeton. (2008) Nonviral Delivery for Genomic Therapy of Cancer. World Journal of Surgery 33:4, pages 685-697.
Crossref
Jeff S. Isenberg, Gema Martin-Manso, Justin B. Maxhimer & David D. Roberts. (2009) Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies. Nature Reviews Cancer 9:3, pages 182-194.
Crossref
Yong Li, Emma Song, Syed M. Abbas Rizvi, Carl A. Power, Julia Beretov, Chand Raja, Paul J. Cozzi, Alfred Morgenstern, Christos Apostolidis, Barry J. Allen & Pamela J. Russell. (2009) Inhibition of Micrometastatic Prostate Cancer Cell Spread in Animal Models By 213Bilabeled Multiple Targeted α Radioimmunoconjugates. Clinical Cancer Research 15:3, pages 865-875.
Crossref
Nancy Smyth TempletonNancy Smyth Templeton. 2008. Gene and Cell Therapy. Gene and Cell Therapy.
Elizabeth R. Plimack, David J. Stewart & Jean-Pierre J. Issa. (2007) Combining Epigenetic and Cytotoxic Therapy in the Treatment of Solid Tumors. Journal of Clinical Oncology 25:29, pages 4519-4521.
Crossref
Michael Hentschel, Timo Paulus, Michael Mix, Ernst Moser, Egbert U. Nitzsche & Ingo Brink. (2007) Analysis of blood flow and glucose metabolism in mammary carcinomas and normal breast: A H2 15O PET and 18F-FDG PET study. Nuclear Medicine Communications 28:10, pages 789-797.
Crossref
Demir Akin, Jennifer Sturgis, Kathy Ragheb, Debby Sherman, Kristin Burkholder, J. Paul. Robinson, Arun K. Bhunia, Sulma Mohammed & Rashid Bashir. (2007) Bacteria-mediated delivery of nanoparticles and cargo into cells. Nature Nanotechnology 2:7, pages 441-449.
Crossref
David J. Stewart. (2007) Mechanisms of resistance to cisplatin and carboplatin. Critical Reviews in Oncology/Hematology 63:1, pages 12-31.
Crossref
Ling Zhang, Lifang Gao, Lijuan Zhao, Baofeng Guo, Kun Ji, Yong Tian, Jinguo Wang, Hao Yu, Jiadi Hu, Dhananjaya V. Kalvakolanu, Dennis J. Kopecko, Xuejian Zhao & De-Qi Xu. (2007) Intratumoral Delivery and Suppression of Prostate Tumor Growth by Attenuated Salmonella enterica serovar typhimurium Carrying Plasmid-Based Small Interfering RNAs . Cancer Research 67:12, pages 5859-5864.
Crossref
Joseph G. Rajendran & David A. Mankoff. 2007. In Vivo Imaging of Cancer Therapy. In Vivo Imaging of Cancer Therapy 47 71 .
Nancy Smyth Templeton. 2006. Encyclopedia of Molecular Cell Biology and Molecular Medicine. Encyclopedia of Molecular Cell Biology and Molecular Medicine.
Daniel N. Chatzifotiadis, Julia W. Buchanan & Richard L. Wahl. 2006. Oncology. Oncology 449 483 .
N.V. Rajeshkumar, Aarati Rai & Anil Gulati. (2005) Endothelin B receptor agonist, IRL 1620, enhances the anti-tumor efficacy of paclitaxel in breast tumor rats. Breast Cancer Research and Treatment 94:3, pages 237-247.
Crossref
Gunnar Brix, Alexandra Schlicker, Walter Mier, Peter Peschke & Matthias E. Bellemann. (2005) Biodistribution and pharmacokinetics of the 19F-labeled radiosensitizer 3-aminobenzamide: assessment by 19F MR imaging. Magnetic Resonance Imaging 23:9, pages 967-976.
Crossref
Quing Zhu, Edward B. Cronin, Allen A. Currier, Hugh S. Vine, Minming Huang, NanGuang Chen & Chen Xu. (2005) Benign versus Malignant Breast Masses: Optical Differentiation with US-guided Optical Imaging Reconstruction. Radiology 237:1, pages 57-66.
Crossref
William B. Eubank & David A. Mankoff. (2005) Evolving role of positron emission tomography in breast cancer imaging. Seminars in Nuclear Medicine 35:2, pages 84-99.
Crossref
Quing Zhu, Scott H. Kurtzman, Poornima Hegde, Susan Tannenbaum, Mark Kane, Minming Huang, Nan Guang Chen, Bipin Jagjivan & Kristen Zarfos. (2005) Utilizing Optical Tomography with Ultrasound Localization to Image Heterogeneous Hemoglobin Distribution in Large Breast Cancers. Neoplasia 7:3, pages 263-270.
Crossref
G. Paganelli. 2005. Molecular Imaging. Molecular Imaging 73 84 .
A.P. Zbar. (2004) The immunology of colorectal cancer. Surgical Oncology 13:2-3, pages 45-53.
Crossref
Géraldine Le Duc, Stéphanie Corde, Anne-Marie Charvet, Hélène Elleaume, Régine Farion, Jean-François Le Bas & François Estève. (2004) In Vivo Measurement of Gadolinium Concentration in a Rat Glioma Model by Monochromatic Quantitative Computed Tomography. Investigative Radiology 39:7, pages 385-393.
Crossref
William B Eubank & David A Mankoff. (2004) Current and future uses of positron emission tomography in breast cancer imaging. Seminars in Nuclear Medicine 34:3, pages 224-240.
Crossref
Nancy Smyth TempletonNancy Smyth Templeton. 2003. Gene and Cell Therapy. Gene and Cell Therapy 287 299 .
Richard L McGough, Paul D Fadale & Richard M Terek. (2003) Soft-Tissue Sarcoma: A Cause of Increased Interstitial Pressure. Orthopedics 26:11, pages 1151-1152.
Crossref
Sophie de Boüard, Jean-Sébastien Guillamo, Christo Christov, Nathalie Lefévre, Pierre Brugières, Eleonora Gola, Pauline Devanz, Stefano Indraccolo & Marc Peschanski. (2003) Antiangiogenic Therapy Against Experimental Glioblastoma Using Genetically Engineered Cells Producing Interferon-α, Angiostatin, or Endostatin. Human Gene Therapy 14:9, pages 883-895.
Crossref
C.V. Borlongan & D.F. Emerich. (2003) Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport. Brain Research Bulletin 60:3, pages 297-306.
Crossref
C. Dragoiescu, O. S. Hoekstra, D. J. Kuik, P. Lips, M. A. B. D. Plaizier, P. T. R. Rodrigus, D. A. K. C. J. M. Huijsmans, J. G. Ribot, J. Kuijpens, J. W. W. Coebergh & G. J. J. Teule. (2003) Feasibility of a randomized trial on adjuvant radio-iodine therapy in differentiated thyroid cancer. Clinical Endocrinology 58:4, pages 451-455.
Crossref
Jörgen Carlsson, Erika Bohl Kullberg, Jacek Capala, Stefan Sjöberg, Katarina Edwards & Lars Gedda. (2003) Ligand liposomes and boron neutron capture therapy. Journal of Neuro-oncology 62:1-2, pages 47-59.
Crossref
Jörgen Carlsson, Eva Forssell Aronsson, Sven-Ola Hietala, Torgny Stigbrand & Jan Tennvall. (2003) Tumour therapy with radionuclides: assessment of progress and problems. Radiotherapy and Oncology 66:2, pages 107-117.
Crossref
Nancy Smyth Templeton. (2002) Liposomal Delivery of Nucleic Acids In Vivo . DNA and Cell Biology 21:12, pages 857-867.
Crossref
David A Mankoff, Lisa K Dunnwald, Julie R Gralow, Georgiana K Ellis, Erin K Schubert, Aaron W Charlop, Jeffrey Tseng, Kristine J Rinn & Robert B Livingston. (2002) [Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow. Nuclear Medicine and Biology 29:7, pages 719-727.
Crossref
Y Li, S M A Rizvi, M Ranson & B J Allen. (2002) 213Bi-PAI2 conjugate selectively induces apoptosis in PC3 metastatic prostate cancer cell line and shows anti-cancer activity in a xenograft animal model. British Journal of Cancer 86:7, pages 1197-1203.
Crossref
Y Li, S M A Rizvi, M Ranson & B J Allen. (2002) 213Bi-PAI2 conjugate selectively induces apoptosis in PC3 metastatic prostate cancer cell line and shows anti-cancer activity in a xenograft animal model. British Journal of Cancer 86:7, pages 1197-1203.
Crossref
Gerald L. DeNardo, Jeffery Schlom, Donald J. Buchsbaum, Ruby F. Meredith, Joseph A. O'Donoghue, George Sgouros, John L. Humm & Sally J. DeNardo. (2002) Rationales, evidence, and design considerations for fractionated radioimmunotherapy. Cancer 94:S4, pages 1332-1348.
Crossref
Andrew P. Zbar. 2002. Immunology for Surgeons. Immunology for Surgeons 193 213 .
Seyed K. Imam. (2001) Status of Radioimmunotherapy in the New Millennium. Cancer Biotherapy and Radiopharmaceuticals 16:3, pages 237-256.
Crossref
Tatsuhiro Joki, Marcelle Machluf, Anthony Atala, Jianhong Zhu, Nicholas T. Seyfried, Ian F. Dunn, Toshiaki Abe, Rona S. Carroll & Peter McL. Black. (2001) Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nature Biotechnology 19:1, pages 35-39.
Crossref
Ralph E. Durand & Peggy L. Olive. 2001. Cytometry: Part B. Cytometry: Part B 211 233 .
Mario Sznol, Stanley L. Lin, David Bermudes, Li-mou Zheng & Ivan King. (2000) Use of preferentially replicating bacteria for the treatment of cancer. Journal of Clinical Investigation 105:8, pages 1027-1030.
Crossref
B. Endrich & P. Vaupel. 2000. Blood Perfusion and Microenvironment of Human Tumors. Blood Perfusion and Microenvironment of Human Tumors 19 39 .
Victor W.M. van Hinsbergh, Annemie Collen & Pieter Koolwijk. (1999) Angiogenesis and anti-angiogenesis: Perspectives for the treatment of solid tumors. Annals of Oncology 10, pages S60-S63.
Crossref
J. Tschmelitsch. (1999) Current status and future directions of radioimmunotherapyRadioimmuntherapie — Ergebnisse und Entwicklungsmöglichkeiten. European Surgery 31:1, pages 26-29.
Crossref
Hidde J. HaismaM. Fleur SerneeErik HooijbergRuud H. BrakenhoffIda H. v.d. Meulen-MuilemanHerbert M. PinedoEpie Boven. (1998) Construction and Characterization of a Fusion Protein of Single-Chain Anti-CD20 Antibody and Human β-Glucuronidase for Antibody-Directed Enzyme Prodrug Therapy. Blood 92:1, pages 184-190.
Crossref
SHARON THOMSEN & DERECK TATMAN. (1998) Physiological and Pathological Factors of Human Breast Disease That Can Influence Optical Diagnosisa. Annals of the New York Academy of Sciences 838:1 ADVANCES IN O, pages 171-193.
Crossref
Donald J. Buchsbaum. (1997) Experimental tumor targeting with radiolabeled ligands. Cancer 80:S12, pages 2371-2377.
Crossref
S. Thomsen. (1997) Anatomical complexities of optical diagnostic targets in vivo: to discover the abnormal, one has to know first the normal. Anatomical complexities of optical diagnostic targets in vivo: to discover the abnormal, one has to know first the normal.
Urs O. Häfeli, Gayle J. Pauer, William K. Roberts, John L. Humm & Roger M. Macklis. 1997. Scientific and Clinical Applications of Magnetic Carriers. Scientific and Clinical Applications of Magnetic Carriers 501 516 .
Ke-lin Qu-hong, J.A. Nagy, I.A. Eckelhoefer, E.M. Masse, A.M. Dvorak & H.F. Dvorak. (1996) Vascular targeting of solid and ascites tumours with antibodies to vascular endothelial growth factor. European Journal of Cancer 32:14, pages 2467-2473.
Crossref
E.B. van Dieren, M.A.B.D. Plaizier, A. van Lingen, J.C. Roos, G.W. Barendsen & G.J.J. Teule. (1996) Absorbed dose distribution of the auger emitters 67Ga and 125I and the β-emitters 67Cu, 90Y, 131I, and 186Re as a function of tumor size, uptake, and intracellular distribution. International Journal of Radiation Oncology*Biology*Physics 36:1, pages 197-204.
Crossref
M.J. Dworkin, J. Zweit, P. Carnochan, B. Deehan & T.G. Allen-Mersh. (1996) Effect of regional angiotensin ii infusion on the relationship between tumour blood flow and fluorouracil uptake in a liver metastasis animal model. European Journal of Cancer 32:9, pages 1580-1584.
Crossref
Marrije R. Buist, Peter Kenemans, Carla F. M. Molthoff, Jan C. Roos, Wim Den Hollander, Mariel Brinkhuis & Jan P. A. Baak. (2006) Tumor uptake of intravenously administered radiolabeled antibodies in ovarian carcinoma patients in relation to antigen expression and other tumor characteristics. International Journal of Cancer 64:2, pages 92-98.
Crossref
Andreas Mühler. (1995) Assessment of myocardial perfusion using contrast-enhanced MR imaging: Current status and future developments. Magma: Magnetic Resonance Materials in Physics, Biology, and Medicine 3:1, pages 21-33.
Crossref
Richard B. Wilder, Gerald L. Denardo & Sally J. Denardo. (1994) Treatment of cancer with intratumoral infusion of radioisotopes. International Journal of Radiation Oncology*Biology*Physics 30:3, pages 737-739.
Crossref
Urs O. Häfeli, Siobhan M. Sweeney, Beverly A. Beresford, Edward H. Sim & Roger M. Macklis. (2004) Magnetically directed poly(lactic acid) 90 Y‐microspheres: Novel agents for targeted intracavitary radiotherapy . Journal of Biomedical Materials Research 28:8, pages 901-908.
Crossref
Wanda Auerbach & Robert Auerbach. (1994) Angiogenesis inhibition: A review. Pharmacology & Therapeutics 63:3, pages 265-311.
Crossref
David E. Kerr, Ursula S. Garrigues, Philip M. Wallace, Karl Erik Hellstrom, Ingegerd Hellstrom & Peter D. Senter. (2002) Application of monoclonal antibodies against cytosine deaminase for the in vivo clearance of a cytosine deaminase immunoconjugate. Bioconjugate Chemistry 4:5, pages 353-357.
Crossref
J. M. Wang, S. Kumar, D. Pye, J. Krupinski, R. D. Hunter & A. J. Van Agthoven. (2006) A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues. International Journal of Cancer 54:3, pages 363-370.
Crossref
Juliana Denekamp. 1992. Angiogenesis in Health and Disease. Angiogenesis in Health and Disease 157 171 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.